The Child with Hematologic or Immunologic Dysfunction

Decreased oxygen-carrying capacity of blood. This condition directly leads to anemia, as insufficient hemoglobin or red blood cells impairs the blood's ability to transport oxygen effectively, resulting in fatigue and weakness. A: Increased blood viscosity. Elevated viscosity can hinder blood flow but does not directly lead to anemia or reduce the oxygen-carrying capacity of red blood cells. B: Depressed hematopoietic system. While a malfunctioning hematopoietic system can affect red blood cell production, it does not specifically address the immediate cause of decreased oxygen transport associated with anemia. C: Presence of abnormal hemoglobin. Abnormal hemoglobin can cause specific types of anemia, but its presence alone does not encompass the broader mechanism of impaired oxygen delivery that characterizes anemia.

Minimizing energy expenditure to decrease cardiac workload is essential for the child, given her low hemoglobin level of 6.4 g/dl. This condition can lead to inadequate oxygen supply, necessitating immediate intervention to stabilize her cardiovascular system. A: Reduce environmental stimulation to prevent seizures. While minimizing stimulation can benefit a child with neurological concerns, the primary issue here is severe anemia requiring more direct interventions. B: Have the laboratory repeat the analysis with a new specimen. Repeating the hemoglobin test does not address the immediate risks posed by the child's critically low hemoglobin levels and muscle weakness. D: Administer intravenous fluids to correct the dehydration. Although hydration is important, the more pressing concern is to address the low hemoglobin level and associated cardiac workload rather than just dehydration.

Transfusing red blood cells (RBCs) will increase the child’s energy levels and reduce fatigue associated with severe anemia. This procedure restores hemoglobin levels, enhancing oxygen delivery to tissues and improving overall vitality. A: Allow her parents to come visit her. Visiting parents does not address the child's medical condition or the physiological need for red blood cells, which directly relates to anemia management. B: Fight the infection that she now has. While infections can cause anemia, transfusing RBCs primarily aims to improve oxygen supply and energy levels, not directly combat infections. D: Help her body stop bleeding by forming a clot (scab). RBC transfusions are not designed to promote clotting; they primarily serve to replenish hemoglobin and support oxygen transport in the bloodstream.

The manifestations are most suggestive of circulatory overload. This condition is characterized by symptoms such as dyspnea, distended neck veins, and cyanosis, indicating fluid volume excess and increased venous pressure during the transfusion process. A: Air embolism Symptoms of air embolism typically include sudden respiratory distress and cardiovascular instability, which do not align with the signs presented here, particularly the neck vein distension. B: Allergic reaction While allergic reactions can cause discomfort, symptoms like precordial pain and cyanosis are not typical indicators, which makes this option less applicable to the scenario. C: Hemolytic reaction Hemolytic reactions primarily present with fever, chills, and hemoglobinuria; the specific symptoms described do not fit the classic profile of a hemolytic response during a transfusion.

Cows milk is a poor source of iron. During infancy, reliance on cow's milk can lead to insufficient iron intake, as it lacks adequate iron content necessary for healthy development, increasing the risk of iron-deficiency anemia. B: Iron cannot be stored during fetal development. Fetal development allows for iron storage, but the depletion of these stores occurs over time, not directly tied to the inability to store iron. C: Fetal iron stores are depleted by 1 month of age. While fetal iron stores do decrease, they typically last longer than one month, so this option oversimplifies the timing of depletion. D: Dietary iron cannot be started until 12 months of age. Infants can receive iron through fortified foods or supplements before 12 months, making this statement misleading regarding the timing for dietary iron introduction.

Iron deficiency anemia in infants results from a reduction in the amount of oxygen available to tissues due to insufficient hemoglobin levels, impacting their overall growth and development. C: It results from a decreased intake of milk and the premature addition of solid foods. While dietary changes can contribute, anemia primarily stems from inadequate iron, not solely from food intake patterns. A: It is caused by depression of the hematopoietic system. This option mischaracterizes the condition; iron deficiency anemia primarily arises from a lack of iron, not direct suppression of blood cell production. B: Diagnosis is easily made because of the infant's emaciated appearance. Diagnosis often requires specific blood tests; emaciation is not a definitive indicator of iron deficiency anemia, as symptoms can be subtle.

C: Adequate dosage will turn the stools a tarry green color. This information is crucial for parents to understand that a common side effect of liquid iron preparations is a change in stool color, indicating the medication is being absorbed effectively. A: Give with meals. Administering iron with meals can reduce absorption efficiency, potentially leading to inadequate iron levels for the infant, which is counterproductive to the treatment. B: Stop immediately if nausea and vomiting occur. While nausea and vomiting can occur, stopping the medication without consulting a healthcare provider may lead to untreated iron deficiency anemia. D: Allow preparation to mix with saliva and bathe the teeth before swallowing. This method can be misleading, as it may increase the risk of dental staining and does not enhance absorption or effectiveness of the iron.

Perform a splenectomy. This intervention is vital for managing hereditary spherocytosis as it addresses the underlying issue of the spleen destroying abnormal red blood cells, significantly improving anemia and overall health. B: Supplement the diet with calcium. While calcium is important for bone health, it does not address the specific issues related to hereditary spherocytosis and does not improve red blood cell survival or anemia. C: Institute a maintenance transfusion program. Although transfusions can temporarily alleviate anemia, they do not resolve the underlying condition of hereditary spherocytosis and may lead to complications such as iron overload. D: Increase intake of iron-rich foods such as meat. Iron intake does not directly impact the hemolysis caused by hereditary spherocytosis; instead, it could lead to excess iron accumulation without improving the child's condition.

Sickle cell anemia occurs when the normal adult hemoglobin is partly or completely replaced by abnormal hemoglobin. This condition leads to distorted red blood cells, causing blockages in blood vessels and various complications. A: Aplastic anemia results from the failure of bone marrow to produce sufficient blood cells, not from the replacement of hemoglobin. It involves a different pathological mechanism entirely. C: Thalassemia major is characterized by reduced production of normal hemoglobin chains, leading to anemia. However, it does not involve the replacement of hemoglobin with an abnormal form. D: Iron deficiency anemia arises from insufficient iron, leading to reduced hemoglobin production. This condition does not involve any replacement of hemoglobin but rather a deficiency in its building blocks.

Each sibling has a 25% chance of having SCA. This statement accurately reflects the genetic inheritance pattern of sickle cell anemia, which follows an autosomal recessive pattern where both parents must carry the gene for a child to be affected. A: SCA is not inherited. Sickle cell anemia is indeed inherited, stemming from mutations in the hemoglobin gene passed down from parents to offspring. B: All siblings will have SCA. This scenario is not possible since only a quarter of siblings would inherit the disease if both parents are carriers of the sickle cell trait. D: There is a 50% chance of siblings having SCA. This overestimates the likelihood; it only accounts for the possibility of each sibling being a carrier rather than being affected by the disease itself.

Increased red blood cell (RBC) destruction. The clinical manifestations of sickle cell anemia arise primarily from the rapid breakdown of sickled red blood cells, leading to anemia, pain crises, and organ damage due to insufficient oxygen delivery. A: Decreased blood viscosity. Sickle cell anemia is characterized by increased viscosity due to sickle-shaped cells, not decreased viscosity, which can worsen blood flow and oxygen delivery. B: Deficiency in coagulation. Sickle cell anemia primarily involves issues with red blood cells rather than coagulation factors; coagulation deficiencies do not capture the essence of the disease's pathology. D: Greater affinity for oxygen. Sickle hemoglobin does not demonstrate a greater affinity for oxygen; instead, it impairs oxygen delivery, contributing to the symptoms associated with sickle cell anemia.

Hydration and pain management are crucial therapeutic interventions for a child in vasoocclusive sickle cell crisis. These strategies help alleviate pain, improve blood flow, and reduce the risk of further complications during such episodes. B: Oxygenation and factor VIII replacement do not address the specific needs of vasoocclusive crises, as oxygenation is typically less critical, and factor VIII is unrelated to sickle cell disease. C: Electrolyte replacement and administration of heparin do not directly target the pain relief and hydration necessary for managing a vasoocclusive sickle cell crisis effectively. D: Correction of alkalosis and reduction of energy expenditure do not directly alleviate pain or improve circulation in sickle cell crises, which are the primary concerns during such episodes.

Notify the practitioner because chest syndrome is suspected. Prompt notification of the practitioner is critical in this situation. Given the child's symptoms, including severe pain, fever, and respiratory distress, immediate medical evaluation is essential for timely intervention and management of potential complications, such as acute chest syndrome, which can arise from sickle cell anemia. A: Administer 100% oxygen to relieve hypoxia. While oxygen may be beneficial later, initial assessment and diagnosis take precedence to determine the underlying cause of symptoms before treatment. C: Infuse intravenous antibiotics as soon as cultures are obtained. Although antibiotics are crucial for infection management, they should follow an immediate assessment and communication with the practitioner to address urgent symptoms effectively. D: Give ordered pain medication to relieve symptoms of pain episode. Pain management is important, but it does not address the potential life-threatening condition indicated by the child's acute respiratory and systemic symptoms; prioritization of assessment is vital.

Encourage checking for moist mucous membranes. This assessment indicates adequate hydration, helping to prevent sickling episodes and reduce the risk of vasoocclusive crises in children with sickle cell anemia. A: Encourage drinking. While promoting fluid intake is vital, assessing mucous membranes provides direct evidence of hydration status, which is more critical for effective management in this context. B: Keep accurate records of output. Documenting output is important for overall management, but it doesn't directly assess the immediate hydration status of the child, making it less relevant. D: Monitor the concentration of the child's urine. While urine concentration can indicate hydration levels, it is a more indirect measure than checking for moist mucous membranes, which offers immediate feedback.

C: Increased incidence occurs in families of Mediterranean extraction. This statement accurately reflects the genetic basis of b-thalassemia major, as it is most prevalent among individuals of Mediterranean descent due to historical genetic factors. A: It is an acquired hemolytic anemia. This description mischaracterizes b-thalassemia major, which is a hereditary disorder, not an acquired condition resulting from external factors affecting red blood cells. B: Inadequate numbers of red blood cells (RBCs) are present. While b-thalassemia major leads to anemia, it specifically involves ineffective erythropoiesis rather than merely insufficient RBC quantity, thus missing the disorder's complexity. D: It commonly occurs in individuals from West Africa. Although thalassemia can be found in various populations, its primary incidence is among Mediterranean families, making this statement less accurate in describing its epidemiology.

Frequent blood transfusions are the most appropriate therapeutic intervention for a child with b-thalassemia major. This treatment helps to manage anemia, improve oxygen delivery, and reduce complications associated with the disease. A: Oxygen therapy does not address the underlying anemia caused by b-thalassemia major and is unlikely to provide significant benefits for the child’s condition. B: Supplemental iron can lead to iron overload, which is particularly detrimental in b-thalassemia major patients who already struggle with iron accumulation from frequent transfusions. C: Adequate hydration is important for overall health but does not specifically target the anemia or the complications associated with b-thalassemia major, making it insufficient as a primary intervention.

Infusion of deferoxamine assists in minimizing iron overload caused by chronic transfusion therapy. This chelating agent effectively binds excess iron in the body, facilitating its excretion and reducing toxic accumulation. A: Magnetic therapy lacks scientific support for treating iron overload and does not address the underlying issue of excess iron in patients undergoing chronic transfusion therapy. C: Hemoglobin electrophoresis is a diagnostic test used to identify different types of hemoglobin, not a treatment for managing iron overload resulting from repeated blood transfusions. D: Washing red blood cells (RBCs) to reduce iron does not significantly decrease the overall iron burden from chronic transfusions, as the majority of iron comes from the transfused blood itself.

Aplastic anemia is the condition where all the formed elements of the blood are simultaneously depressed. This disorder results from the failure of the bone marrow to produce sufficient blood cells, affecting red blood cells, white blood cells, and platelets. This widespread deficiency leads to severe complications, including increased risk of infections and bleeding. B: Sickle cell anemia primarily affects red blood cells, causing them to deform and obstruct blood flow, but it does not simultaneously depress all blood cell types. C: Thalassemia major primarily impacts hemoglobin production, leading to anemia, but it does not cause a simultaneous depression of all blood components, focusing mainly on red blood cells. D: Iron deficiency anemia typically results in a reduction of red blood cells due to inadequate iron, but it does not affect white blood cells or platelets in a simultaneous manner.

Immunosuppressive therapy is a crucial intervention for children without a matched sibling donor for aplastic anemia. This approach helps to suppress the immune system, allowing the bone marrow to recover and produce healthy blood cells. A: Antibiotics target infections and do not address the underlying issue of bone marrow failure in aplastic anemia. They are supportive but not curative. B: Antiretroviral drugs are designed for HIV treatment and do not have a role in managing aplastic anemia, which requires different therapeutic strategies. C: Iron supplementation addresses iron deficiency but is irrelevant for aplastic anemia's primary concern of insufficient blood cell production and bone marrow dysfunction.